Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 381

The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.

Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks

Robyr, D.·2000·Molecular Endocrinology

Abstract

The nuclear hormone receptors are transcriptional regulators that activate gene expression upon binding of their respective ligands. A new class of protein, termed coregulators, has emerged during the last few years. These proteins have the faculty to repress (corepressors) or to enhance (coactivators) the activity of genes regulated by nuclear hormone receptors in a ligand-dependent fashion. In this review we describe most of these coregulators and discuss their mode of action. In particular, we comment on the link between coregulators and histone acetylation, which is a crucial event in the transcriptional response within chromatin. We describe novel alternative pathways, which elicit the recruitment of coregulators independently of the presence of any ligand and speculate on how the convergence of ligand-dependent and -independent mechanisms might enhance the transcriptional response of target genes. Nuclear hormone receptors are ligand-inducible transcription factors that are involved in a number of physiological and cellular events (see Table 1 for nuclear receptor nomenclature). Together, they form a superfamily, which includes the classic steroid receptors (androgen, estrogen, glucocorticoid, mineralocorticoid, and progesterone receptors), the thyroid, vitamin D, and retinoid receptors, as well as many others that have been characterized more recently. All of them share common functional domains named A to F. The N-terminal A/B region is weakly conserved among the members of the superfamily, has a variable length, and contains an autonomous activation function (AF-1). The conserved C domain is the DNA-binding domain, which consists of two zinc-finger-like motifs. The D domain is a variable hinge. The multifunctional C-terminal half of the protein (domain E) encompasses the ligand-binding domain (LBD), a second activation function (AF-2), a dimerization domain, and a region involved in nuclear localization. The AF-2 autonomous activation domain (AF-2 AD) is composed of an amphipathic α-helix that is highly conserved among nuclear receptors and is critical for transcriptional activation (1–4). The most C-terminal region (domain F) is variable and has no known function. This domain is absent in some receptors such as the progesterone receptor (PR), peroxisome proliferator-activated receptors (PPAR), and retinoid receptors [retinoic acid receptor (RAR), retinoid X receptor (RXR)]. Nomenclature According to the Nuclear Receptors Nomenclature Committee, 1999 Nomenclature According to the Nuclear Receptors Nomenclature Committee, 1999 Transcriptional activation by both AF-1 and AF-2 of the estrogen receptor (ER) is cell type specific and relies on the promoter context of the hormone-response element (HRE) (5). This suggests the existence of different mediating or coactivating proteins, several of which have been identified to date (see below). These mediators interact with the LBD and some are capable of increasing the AF-2 response in a ligand-dependent fashion. On certain promoters, AF-1 and AF-2 must synergize to reach efficient transactivation. The observation of transcriptional interference or squelching between steroid hormone receptors provided evidence for the existence of limiting common transcriptional cofactors that mediate AF-2 function (6, 7). The subsequent biochemical identification of several nuclear receptor-interacting proteins in a ligand-dependent manner supported this hypothesis (8) (Table 2). These mediators or coactivators are required to achieve efficient transcription (reviewed in Refs. 9–11). Nuclear Receptor Cofactors—Part I Nuclear Receptor Cofactors—Part I Numerous potential receptor-interacting proteins were identified and described in the past few years (Table 2), and many others will certainly be discovered in the near future. This rapid increase has led to some confusion in the nomenclature and raised questions about the definition of a coactivator. A real coactivator must fulfill certain requirements. First it must interact directly with the activation domain of a nuclear receptor in an agonist-dependent manner (but not in the presence of an antagonist), leading to enhancement of the receptor activation function. Most of the potential cofactors meet this definition. A coactivator should also interact with components of the basal transcription machinery. Finally, coactivators should not enhance the basal transcriptional activity by their own, although they contain an autonomous activation function (12, 13). Indeed, in the absence of a nuclear hormone receptor, coactivators cannot be recruited to promoters and therefore cannot coactivate transcription. Here, we will first discuss some well characterized coactivators and then we will comment on proteins whose coactivator status is not clearly established. Among all the described coactivators to date, SRC-1 (steroid receptor coactivator 1) has attracted much attention. The human SRC-1 was first discovered as a ligand-dependent

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.14.3.329

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 148 references

Cited by

See all 381

Metadata

Authors
Robyr, D.
Venue
Molecular Endocrinology
Published
2000-03-01
Volume
14
Issue
3
Pages
329-347
ISSN
0888-8809 (ISSN-L)
OpenAlex
W2131103656
Cited by
381
References
148
FWCI
30.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks. https://app.cochat.ai/papers/10.1210/me.14.3.329
The paper
Robyr, D. (2000). Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks. Molecular Endocrinology. https://doi.org/10.1210/me.14.3.329

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.